Jo Anne Zujewski

3.7k total citations · 1 hit paper
29 papers, 1.6k citations indexed

About

Jo Anne Zujewski is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Jo Anne Zujewski has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Cancer Research and 11 papers in Genetics. Recurrent topics in Jo Anne Zujewski's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). Jo Anne Zujewski is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). Jo Anne Zujewski collaborates with scholars based in United States, Canada and Switzerland. Jo Anne Zujewski's co-authors include Robert J. Gray, Sally Hunsberger, Joseph A. Sparano, Clifford A. Hudis, Rebecca A. Enos, William E. Barlow, Kathleen I. Pritchard, J. W. Chapman, Richard D. Gelber and Joseph P. Costantino and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jo Anne Zujewski

29 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

2007 558 citations Clifford A. Hudis, William E. Barlow et al. Journal of Clinical Oncology profile →

Peers

Jo Anne Zujewski

ONCOL

GENET

PHEOH

Holm Eggemann Germany

P. Kelly Marcom United States

Konstantinos Tryfonidis Belgium

B. Norris Canada

K Holli Finland

Chiu-Kit Tse United States

V J Bardou France

Foluso O. Ademuyiwa United States

Jean‐Sébastien Brunet Canada

Ann Knoop Denmark

Holm Eggemann Germany

Jo Anne Zujewski

651 ×0.9

694 ×1.0

ONCOL

382 ×0.9

GENET

205 ×0.6

PHEOH

231 ×0.7

Citations per year, relative to Jo Anne Zujewski Jo Anne Zujewski (= 1×) peers Holm Eggemann

Countries citing papers authored by Jo Anne Zujewski

Since Specialization

Citations

This map shows the geographic impact of Jo Anne Zujewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Anne Zujewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Anne Zujewski more than expected).

Fields of papers citing papers by Jo Anne Zujewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Anne Zujewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Anne Zujewski. The network helps show where Jo Anne Zujewski may publish in the future.

Co-authorship network of co-authors of Jo Anne Zujewski

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Anne Zujewski. A scholar is included among the top collaborators of Jo Anne Zujewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Anne Zujewski. Jo Anne Zujewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alemany, Carlos, Manish R. Patel, Zahi Mitri, et al.. (2021). Abstract P037: A phase 1/2 dose escalation and expansion study of OP-1250 in adults with advanced and/or metastatic hormone receptor-positive (HR+), HER2-negative (HER2−) breast cancer. Molecular Cancer Therapeutics. 20(12_Supplement). P037–P037. 3 indexed citations

Zujewski, Jo Anne & Larry Rubinstein. (2017). CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data. npj Breast Cancer. 3(1). 27–27. 27 indexed citations

Gingras, Isabelle, Eileen Holmes, Evandro de Azambuja, et al.. (2016). Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial. JNCI Journal of the National Cancer Institute. 109(8). 19 indexed citations

Connolly, Roisín M., Fengmin Zhao, Kathy Ann Miller, et al.. (2015). E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.. Journal of Clinical Oncology. 9 indexed citations

Zujewski, Jo Anne. (2015). Changing Paradigms in Breast Cancer Therapeutics: An Extended Abstract. Medical Principles and Practice. 25(Suppl. 2). 73–75. 3 indexed citations

Sparano, Joseph A., Robert J. Gray, Jo Anne Zujewski, et al.. (2014). Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity.. Journal of Clinical Oncology. 32(26_suppl). 36–36. 1 indexed citations

Fumagalli, Debora, Philippe L. Bédard, Zeina Nahleh, et al.. (2012). A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. The Lancet Oncology. 13(6). e240–e248. 52 indexed citations

Zujewski, Jo Anne, et al.. (2010). Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Research and Treatment. 127(1). 251–257. 42 indexed citations

Harlan, Linda C., Jo Anne Zujewski, Marc T. Goodman, & Jennifer L. Stevens. (2010). Breast cancer in men in the United States. Cancer. 116(15). 3558–3568. 52 indexed citations

10.

Korde, Larissa A., Jo Anne Zujewski, Sharon H. Giordano, et al.. (2010). Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations. Journal of Clinical Oncology. 28(12). 2114–2122. 303 indexed citations

11.

Korde, Larissa A., Lara Lusa, Lisa M. McShane, et al.. (2009). Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Research and Treatment. 119(3). 685–699. 79 indexed citations

12.

Zujewski, Jo Anne, et al.. (2008). Trial Assessing Individualized Options for Treatment for Breast Cancer: The TAILORx Trial. Future Oncology. 4(5). 603–610. 88 indexed citations

13.

Leyland‐Jones, Brian, Christine B. Ambrosone, John M.S. Bartlett, et al.. (2008). Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials. Journal of Clinical Oncology. 26(34). 5638–5644. 55 indexed citations

14.

Come, Steven E., Aman U. Buzdar, James N. Ingle, et al.. (2007). Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference. Cancer. 112(S3). 673–678. 7 indexed citations

15.

Eng‐Wong, Jennifer & Jo Anne Zujewski. (2007). Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer. Cancer. 112(S3). 723–729. 2 indexed citations

16.

Rapkiewicz, Amy, Virginia Espina, Jo Anne Zujewski, et al.. (2007). The needle in the haystack: Application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer. 111(3). 173–184. 65 indexed citations

17.

Hudis, Clifford A., William E. Barlow, Joseph P. Costantino, et al.. (2007). Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System. Journal of Clinical Oncology. 25(15). 2127–2132. 558 indexed citations breakdown →

18.

Aragon‐Ching, Jeanny B. & Jo Anne Zujewski. (2007). CNS Metastasis: An Old Problem in a New Guise. Clinical Cancer Research. 13(6). 1644–1647. 67 indexed citations

19.

Faupel‐Badger, Jessica M., Sheila A. Prindiville, David Venzon, et al.. (2006). Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 15(6). 1153–1158. 14 indexed citations

20.

Zujewski, Jo Anne, Jennifer Eng‐Wong, Joyce O’Shaughnessy, et al.. (2003). A Pilot Study of Dose Intense Doxorubicin and Cyclophosphamide Followed by Infusional Paclitaxel in High-Risk Primary Breast Cancer. Breast Cancer Research and Treatment. 81(1). 41–51. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact